Venus Remedies (BOM:526953) Retained Earnings : ₹0 Mil (As of Sep. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Venus Remedies Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Venus Remedies's retained earnings for the quarter that ended in Sep. 2024 was ₹0 Mil.

Venus Remedies's quarterly retained earnings declined from Mar. 2024 (₹1,704 Mil) to Jun. 2024 (₹0 Mil) but then stayed the same from Jun. 2024 (₹0 Mil) to Sep. 2024 (₹0 Mil).

Venus Remedies's annual retained earnings increased from Mar. 2022 (₹1,160 Mil) to Mar. 2023 (₹1,421 Mil) and increased from Mar. 2023 (₹1,421 Mil) to Mar. 2024 (₹1,704 Mil).

Venus Remedies Retained Earnings Historical Data

The historical data trend for Venus Remedies's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Venus Remedies Retained Earnings Chart

Venus Remedies Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Retained Earnings

Get a 7-Day Free Trial

133.87

750.57

1,160.25

1,421.28

1,704.31

Venus Remedies Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Retained Earnings	Get a 7-Day Free Trial															-	-	1,704.31	-	-

Venus Remedies Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Venus Remedies (BOM:526953) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Venus Remedies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Venus Remedies Ltd (BOM:526953) » Definitions » Retained Earnings

Traded in Other Exchanges

VENUSREM:India

Address

Plot 51-52, Industrial Area, Phase 1, Panchkula, HR, IND, 134113

Website

https://www.venusremedies.com

Venus Remedies Ltd is an Indian drug manufacturer. It is engaged in manufacturing and trading pharmaceutical products. The company produces biologically active food supplements which include food supplements are natural complexes containing minerals, vitamins, dietary fibers, extracts of medicinal herbs, amino acids and others.

Venus Remedies Headlines

No Headlines